We use cookies and other tracking technologies to provide services while browsing the online page to display unadvertised content and targeted advertising, analyze site traffic, and perceive where our audience is coming from so that they enjoy browsing our online page. By continuing to use our website, you agree to the use of those cookies and agree to our privacy terms. If you would like to see more information about how we process your non-public data, please read our cookie policy and privacy policy.
Our privacy has been reviewed. Please refer to ‘; P = ‘Privacy Policy here’; P = update
Pfizer voluntarily some antibiotics for ‘quality issues’
Pfizer India has introduced a voluntary recall of some life-saving antibiotics due to quality issues. In a letter to resellers, suppliers and hospitals across India, Pfizer requested a temporary suspension of the sale and distribution of Magzex, Zosyn, Magnamycin injections and Magnex forte. with immediate effect. The recall follows “technical problems” at its contract production site.
Delhi: Relatives of Covid warriors whose lives get a cheque for Rs 1 cr
Ministers Imran Hussain and Raaj Kumar Anand visited the homes of Covid-19 warriors who lost their lives in the pandemic and handed over a cheque of Rs 1 crore each on Thursday. They met with the families of Anil Kumar Rawat in Rohini, Rajni Chauhan in Vikaspuri and Madhu Rana in Basaidarapur.
Bivalent booster injections developed and distributed last year targeted two other strains: the Omicron variant as the source virus.
The WHO advisory group, which recommends whether adjustments to the composition of long-term Covid-19 vaccines are needed, said newly approved vaccines continue to be used in line with the agency’s recommendations.
COVID-19 vaccine brands such as Pfizer/BioNtech (PFE. N), Moderna Inc (MRNA. O) and Novavax Inc (NVAX. O) are already releasing versions of their respective XBB. 1. 5 vaccines and other strains circulating lately.
The U. S. Food and Drug Administration is also expected to be able to do so. The U. S. government will hold a specialized external assembly in June to discuss the composition of Covid-19 injection strains by the end of this year; Vaccine brands will want to update their vaccines once strains have been selected.
The new formulations aim to produce antibody responses to XBB. 1. 5 or XBB. 1. 16 variants, the advisory organization said, adding that other formulations or platforms may also be considered to achieve neutralizing antibody responses opposed to XBB lines.
The organization recommended not to add the original strain of covid-19 in vaccines any longer term, due to evidence that the original virus no longer circulates in humans and injections targeting the strain produce “undetectable or very low levels of neutralizing antibodies” unlike variants circulating lately. .
WHO recommends new Covid vaccines target XBB variants
A World Health Organization (WHO) advisory organization on Thursday that this year’s Covid-19 booster vaccines be updated to target one of the dominant XBB variants lately.